Bonus BioGroup Statistics
Total Valuation
Bonus BioGroup has a market cap or net worth of 58.05 million. The enterprise value is 58.97 million.
| Market Cap | 58.05M |
| Enterprise Value | 58.97M |
Important Dates
The next estimated earnings date is Thursday, May 29, 2025.
| Earnings Date | May 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 633.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 30.39 |
| P/TBV Ratio | 30.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.72 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.89 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 1.47.
| Current Ratio | 0.91 |
| Quick Ratio | 0.88 |
| Debt / Equity | 1.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.47 |
| Interest Coverage | -35.73 |
Financial Efficiency
Return on equity (ROE) is -153.47% and return on invested capital (ROIC) is -60.40%.
| Return on Equity (ROE) | -153.47% |
| Return on Assets (ROA) | -50.95% |
| Return on Invested Capital (ROIC) | -60.40% |
| Return on Capital Employed (ROCE) | -179.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -155,912 |
| Employee Count | 49 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.45% in the last 52 weeks. The beta is 0.97, so Bonus BioGroup's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -45.45% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 49.78 |
| Average Volume (20 Days) | 6,940 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.64M |
| Pretax Income | -7.64M |
| Net Income | -7.64M |
| EBITDA | -7.19M |
| EBIT | -7.64M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 1.88 million in cash and 2.80 million in debt, giving a net cash position of -915,081.
| Cash & Cash Equivalents | 1.88M |
| Total Debt | 2.80M |
| Net Cash | -915,081 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.91M |
| Book Value Per Share | 0.00 |
| Working Capital | -199,325 |
Cash Flow
In the last 12 months, operating cash flow was -5.87 million and capital expenditures -93,897, giving a free cash flow of -5.96 million.
| Operating Cash Flow | -5.87M |
| Capital Expenditures | -93,897 |
| Free Cash Flow | -5.96M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bonus BioGroup does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.16% |
| FCF Yield | -10.27% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |